Event Details

Cognition management participated in a discussion of Alzheimer's disease with Drs. Anton Porsteinsson and Martin Sadowski, hosted by Jay Olson, CFA of Oppenheimer & Co Inc. Several important dynamics were addressed, including: 1) the KOL's impressions of current Aduhelm launch environment, 2) importance of targeting toxic Aβ oligomers, 3) novel therapeutic approaches beyond Aβ antibodies, 4) implications of the Icelandic mutation and its protective role, and 5) targeted approaches to modulating the Sigma-2 receptor.

For more information, please contact your Oppenheimer sales representative.